NMDA and AMPA glutamate receptor subtypes in the thoracic spinal cord in lean and obese-diabetic ob/ob mice

Brain Research

Volumn 849, Issue 1-2, 1999, Pages 34-44

  Li, Nicholas ^a   Young, Margaret M ^a   Bailey, Clifford J ^b   Smith, Margaret E ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ASTON UNIVERSITY   (United Kingdom)

Author keywords

AMPA receptor; Glutamate receptor; NMDA receptor; Obese diabetic mouse; Spinal cord; Type 2 diabetes mellitus

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR; DIZOCILPINE; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; FEMALE; LEAN BODY WEIGHT; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; THORACIC SPINAL CORD;

ANIMALS; AUTORADIOGRAPHY; DIZOCILPINE MALEATE; FEMALE; KINETICS; MALE; MICE; MICE, OBESE; NEURONS; OBESITY; QUINOXALINES; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE; SEX CHARACTERISTICS; SPINAL CORD; THINNESS; TRITIUM;

EID: 0032735233     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02070-3     Document Type: Article

References (24)

1. Calcutt N.A., Chaplan S.R. Spinal pharmacology of tactile allodynia in diabetic rats. Br. J. Pharmacol. 122:1997;1478-1482.
2. Cik M., Chazot P.L., Stephenson F.A. Optimal expression of cloned NMDAR1/NMDAR2 heteromeric glutamate receptors: a biochemical characterisation. Biochem. J. 296:1993;877-883.
3. Chabot C., Massicotte G., Milot M., Trudeau F., Gagne J. Impaired modulation of AMPA receptors by calcium-dependent processes in streptozotocin-induced diabetic rats. Brain Res. 768:1997;249-256.
4. Chazot P.L., Coleman S.K., Cik M., Stephenson F.A. Molecular characterization of N-methyl-D-aspartate receptors expressed in mammalian cells yields evidence for the coexistence of three subunit types within a discrete receptor molecule. J. Biol. Chem. 269:1994;24403-24409.
5. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
6. Cole A.J., Saffren D.W., Baraban J.M., Worley P.F. Rapid increase of an immediate early gene messenger in hippocampal neurons by synaptic NMDA receptor activation. Nature. 340:1989;474-476.
7. Furuyama T., Kiyama H., Sato K., Park H.T., Maeno H., Takagi H., Tohyama M. Region-specific expression of subunits of ionotropic glutamate receptors (AMPA-type, KA-type and NMDA receptors) in rat spinal cord with special reference to nociception. Mol. Brain Res. 18:1993;141-151.
8. Gagne J., Milot M., Gelinas S., Lahsaini A., Trudeau F., Martinoli M.G., Massicotte G. Binding properties of glutamate receptors in streptozotocin-induced diabetes in rats. Diabetes. 46:1997;841-846.
9. Greensmith L., Hassan H.K., Vrbova G. Nerve injury increases the susceptibility to N-methyl-D-aspartate neurotoxicity in the developing rat. Neuroscience. 58:1994;727-733.
10. Harati Y. Diabetic peripheral neuropathies. Ann. Intern. Med. 107:1987;546-559.
11. Hughes S., Lowrie M.B., Smith M.E. N-methyl-D-aspartate receptors in motoneurones after unilateral axotomy in the neonatal rat. Dev. Brain Res. 102:1997;13-20.
12. Hughes S., Lowrie M.B., Smith M.E. Evidence for two populations of N-methyl-D-receptors in neonatal rat spinal cord. The effect of peripheral nerve axotomy. Dev. Brain Res. 105:1998;209-217.
13. Hughes S., Smith M.E., Bailey C.J. β-Endorphin and corticotrophin immunoreactivity and specific binding in the neuromuscular system of obese-diabetic mice. Neuroscience. 48:1992;463-468.
14. Laurie D.J., Seeburg P.H. Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition. Eur. J. Pharmacol. 268:1994;335-345.
15. MacDonald S., Smith M.E., Bailey C.J. Expression of β-endorphin and its receptors in the spinal cord of obese-diabetic mice. Neurosci. Lett. 248:1998;85-88.
16. Mentis G.Z., Greensmith L., Vrbova G. Motoneurones destined to die are rescued by blocking N-methyl-D-aspartate receptors by MK-801. Neuroscience. 54:1993;283-285.
17. Monaghan D.T., Bridges R.J., Cotman C.W. The excitatory amino acid receptors: their classes, pharmacology and distinct properties in the function of the central nervous system. Annu. Rev. Pharmacol. Toxicol. 29:1989;365-402.
18. Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H., Burnashev N., Samann B., Seeburg P.H. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science. 256:1992;1217-1221.
19. Moriyoshi K., Masu M., Ishii T., Shigemoto R., Mizuno N., Nakanishi S. Molecular cloning and characterisation of the rat NMDA receptor. Nature. 354:1991;31-37.
20. 2+ permeable kainate/AMPA receptors more abundant in immature brain? Neurosci. Lett. 144:1992;65-69.
21. Sugihara H., Moryoshi K., Ishii T., Masu M., Nakanishi S. Structures and properties of seven isoforms of the NMDA receptor generated by alternative splicing. Biochem. Biophys. Res. Comm. 185:1992;826.
22. Wanaka A., Shiotani Y., Kiyama H., Matsuyama T., Kamada T., Shiosaka S., Tohyama M. Glutamate-like immunoreactive structures in primary sensory neurons in the rat detected by a specific antiserum against glutamate. Exp. Brain Res. 65:1987;691-694.
23. Watanabe M., Inoue Y., Sakimura K., Mishina M. Developmental changes in distribution of NMDA receptor channel subunit mRNAs. NeuroReport. 3:1992;1138.
24. Westlund K.N., McNeill D., Coggeshall R.E. Glutamate immunoreactivity in rat dorsal root axons. Neurosci. Lett. 96:1989;13-17.